Ossianix to generate biopharmaceuticals for nervous system disorders
The biopharmaceuticals are produced utilizing Ossianix’s Osss proprietary single domain antibody platform modeled on the shark vNAR structure. Lundbeck will retain the right to negotiate for certain products
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.